Case Report
BibTex RIS Cite

Valproik Asit Kullanımına Bağlı Liken Planus Olgusu

Year 2019, , 352 - 355, 28.06.2019
https://doi.org/10.31832/smj.523227

Abstract

Erzurum Atatürk Üniversitesi Tıp Fakültesi nöroloji polikliniğinde
idiyopatik jeneralize epilepsi tanısı ile takip edilen ve valproik asit
tedavisi başlandıktan bir buçuk yıl sonra ortaya çıkan döküntüleri
histopatolojik inceleme sonrasında Liken Planus tanısı alan vakayı sunuyoruz.
Olgumuzda döküntüler sadece el-ayak bileklerinde lokalize olup yayılım
göstermediği için tedavisi valproik asit ilaç dozunu azaltma ve lokal
kortikosteroid kullanımı şeklinde düzenlendi. Takibinde likenoid reaksiyonlarda
regresyon izlenmesi nedeni ile ilaç değişikliği yapılmadan tedavisine devam
edildi. Literatürde valproik asit kullanımına sekonder liken planus vakası bildirilmemiştir.

References

  • 1. Aouam K, Bel Hadj Ali H, Youssef M, Chaabane A, Amri M, Boughattas N. A, et al. Carbamazepine‐induced DRESS and HHV6 primary infection: The importance of skin tests. Epilepsia, 2008; 49(9): 1630-33.
  • 2. Chadwick D, Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised doubleblind study. Vigabatrin European Monotherapy Study Group. The Lancet, 1999; 354 (9172):13-19.
  • 3. Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol, 2011; 67(5): 463-470.
  • 4. Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS) Pediatr Dermatol, 2009; 26(5):536-46.
  • 5. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol, 1998; 38(11): 1003-9.
  • 6. Vincent SD, Fotos PG, Baker KA, Williams TP. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol, 1990;70(2):165-71.
  • 7. Mollaoglu N. Oral lichen planus: a review. Br J Oral Maxillofac Surg, 2000;38(4):370-77.
  • 8. Basheer S, Shameena PM, Sudha S, Varma S, Vidyanath S, Varekar A. Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study. J Oral Maxillofac Pathol, 2017;21(3):456.
  • 9. Thompson DF, Skaehill PA. Drug induced lichen planus Pharmacotherapy, 1994; 14(5): 561-71.
  • 10. Roberts DL, Marks R. Skin reactions to carbamazepine. Arch Dermatol, 1981;117(5):273–5.
  • 11. Hajnsek S, Milavec-Puretic V, Nankovic S, Gadze ZP, Filipcic I, Kovac AB, et al. Lichen planus induced by carbamazepine: A case report. Epilepsy& Behavior, 2012; 24(2): 269-71.
Year 2019, , 352 - 355, 28.06.2019
https://doi.org/10.31832/smj.523227

Abstract

References

  • 1. Aouam K, Bel Hadj Ali H, Youssef M, Chaabane A, Amri M, Boughattas N. A, et al. Carbamazepine‐induced DRESS and HHV6 primary infection: The importance of skin tests. Epilepsia, 2008; 49(9): 1630-33.
  • 2. Chadwick D, Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised doubleblind study. Vigabatrin European Monotherapy Study Group. The Lancet, 1999; 354 (9172):13-19.
  • 3. Pereira de Silva N, Piquioni P, Kochen S, Saidon P. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs. Eur J Clin Pharmacol, 2011; 67(5): 463-470.
  • 4. Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS) Pediatr Dermatol, 2009; 26(5):536-46.
  • 5. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol, 1998; 38(11): 1003-9.
  • 6. Vincent SD, Fotos PG, Baker KA, Williams TP. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol, 1990;70(2):165-71.
  • 7. Mollaoglu N. Oral lichen planus: a review. Br J Oral Maxillofac Surg, 2000;38(4):370-77.
  • 8. Basheer S, Shameena PM, Sudha S, Varma S, Vidyanath S, Varekar A. Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study. J Oral Maxillofac Pathol, 2017;21(3):456.
  • 9. Thompson DF, Skaehill PA. Drug induced lichen planus Pharmacotherapy, 1994; 14(5): 561-71.
  • 10. Roberts DL, Marks R. Skin reactions to carbamazepine. Arch Dermatol, 1981;117(5):273–5.
  • 11. Hajnsek S, Milavec-Puretic V, Nankovic S, Gadze ZP, Filipcic I, Kovac AB, et al. Lichen planus induced by carbamazepine: A case report. Epilepsy& Behavior, 2012; 24(2): 269-71.
There are 11 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Articles
Authors

Fatma Şimşek 0000-0003-1662-5534

Publication Date June 28, 2019
Submission Date February 6, 2019
Published in Issue Year 2019

Cite

AMA Şimşek F. Valproik Asit Kullanımına Bağlı Liken Planus Olgusu. Sakarya Tıp Dergisi. June 2019;9(2):352-355. doi:10.31832/smj.523227

30703

SMJ'de yayınlanan makaleler, Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı kapsamında lisanslanır